Innovations in the oncology immunotherapy field
By Intesa Sanpaolo
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori – IRST IRCCS – was founded on one belief: that the struggle against tumours can be won.
Constant progress in tumour prevention, treatment efficacy and ongoing progress in research are all very encouraging.
This centre is the main nodal point in a network of interconnected operational structures, the basis of highly complex technological research and innovative patient treatments.
New oncology immunotherapy developments will be presented here.